[HTML][HTML] Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

Interaction of obesity and infections

NV Dhurandhar, D Bailey, D Thomas - Obesity reviews, 2015 - Wiley Online Library
There is evidence that certain infections may induce obesity. Obese persons may also have
more severe infections and have compromised response to therapies. The objective of this …

Ten-day vonoprazan-amoxicillin dual therapy as a first-line treatment of Helicobacter pylori infection compared with bismuth-containing quadruple therapy

HS Qian, WJ Li, YN Dang, LR Li, XB Xu… - Official journal of the …, 2023 - journals.lww.com
METHODS: A total of 375 treatment-naive, H. pylori-infected subjects were randomly
assigned in a 1: 1: 1 ratio into 3 regimen groups including VHA-dual (vonoprazan 20 mg …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review

AS Alobaid, M Hites, J Lipman, FS Taccone… - International journal of …, 2016 - Elsevier
The increased prevalence of obesity presents challenges for clinicians aiming to provide
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …

Population pharmacokinetics of piperacillin in nonobese, obese, and morbidly obese critically ill patients

AS Alobaid, SC Wallis, P Jarrett, T Starr… - Antimicrobial agents …, 2017 - Am Soc Microbiol
The treatment of infections in critically ill obese and morbidly obese patients is challenging
because of the combined physiological changes that result from obesity and critical illness …

Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy

H Eto, S Suzuki, C Kusano, H Ikehara, R Ichijima… - …, 2021 - Wiley Online Library
Background As a first‐line therapy for Helicobacter pylori, dual therapy with vonoprazan and
amoxicillin (VA‐dual) provides an eradication rate similar to that of vonoprazan‐based triple …

Pharmacokinetics and pharmacodynamics in antibiotic dose optimization

SKB Sy, L Zhuang, H Derendorf - Expert opinion on drug …, 2016 - Taylor & Francis
Introduction: Identifying the optimized dosing regimen and algorithm is critical in the
development of antibiotics. Suboptimal regimens and inappropriate choice of drug give rise …

[HTML][HTML] Pharmacokinetic/pharmacodynamic considerations of beta-lactam antibiotics in adult critically ill patients

AM Masich, MS Heavner, JP Gonzales… - … infectious disease reports, 2018 - Springer
Abstract Purpose of Review Beta-lactam antibiotics are commonly prescribed in critically ill
patients for a variety of infectious conditions. Our understanding of how critical illness alters …

Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients

EK Chung, SC Cheatham, MR Fleming… - The Journal of …, 2015 - Wiley Online Library
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in …